Did you know that 27 pediatric oncology studies have been added to the 3CTN portfolio since April 2014? Follow the weekly C17 Sosido Digest for our new study focus postings, like the one below.

Each pediatric hem/onc site is sent a reporting worksheet every three months.  This sheet shows all 3CTN eligible pediatric studies, or you can search the 3CTN Portfolio Directly at:  http://portfolio.3ctn.ca/

If you notice a study missing from the portfolio, please contact us.  The eligibility criteria are:

  • a cancer intervention clinical trial
  • an academic clinical trial (if a NOL is required, a non-industry organization/institute must be sponsor)
  • open at more that one Canadian site – note that the second site can be an adult oncology program